Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 29, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 29, Issue 11 (2020)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 29, Issue 11 (2020)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Volume 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

DRUG EVALUATION

Article

Mavacamten: a novel small molecule modulator of β-cardiac myosin for treatment of hypertrophic cardiomyopathy

Albree Tower-Rader, Jay Ramchand, Steve E. Nissen & Milind Y. Desai

Pages: 1171-1178

Published online: 20 Sep 2020

AbstractforMavacamten: a novel small molecule modulator of β-cardiac myosin for treatment of hypertrophic cardiomyopathy | Full Text | References | PDF (958.8 KB) | EPUB

1279 Views
10 CrossRef citations
0Altmetric

Article

Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1

Justin D. Lu, Milica Milakovic, Alex G. Ortega-Loayza, Angelo V. Marzano & Afsaneh Alavi

Pages: 1179-1185

Published online: 29 Sep 2020

AbstractforPyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1 | Full Text | References | PDF (556.1 KB) | EPUB

447 Views
16 CrossRef citations
0Altmetric

Drug Evaluation

Article

Ipilimumab: an investigational immunotherapy for glioblastoma

Gilbert Youssef & Jorg Dietrich

Pages: 1187-1193

Published online: 06 Oct 2020

AbstractforIpilimumab: an investigational immunotherapy for glioblastoma | Full Text | References | PDF (302.8 KB) | EPUB

374 Views
11 CrossRef citations
0Altmetric

KEY PAPER EVALUATION

Article

Remdesivir, a remedy or a ripple in severe COVID-19?

Sheila A. Doggrell

Pages: 1195-1198

Published online: 20 Sep 2020

AbstractforRemdesivir, a remedy or a ripple in severe COVID-19? | Full Text | References | PDF (187.4 KB) | EPUB

2328 Views
8 CrossRef citations
0Altmetric

Review

The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials

My-my Huynh, Mary Rose Pambid, Aarthi Jayanthan, Andrew Dorr, Gerrit Los & Sandra E. Dunn

Pages: 1199-1208

Published online: 17 Sep 2020

AbstractforThe dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials | Full Text | References | PDF (1.8 MB) | EPUB

572 Views
16 CrossRef citations
0Altmetric

Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels

Asia Fernández-Carvajal, Rosario González-Muñiz, Gregorio Fernández-Ballester & Antonio Ferrer-Montiel

Pages: 1209-1222

Published online: 29 Sep 2020

AbstractforInvestigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels | Full Text | References | PDF (1.8 MB) | EPUB

320 Views
22 CrossRef citations
0Altmetric

Progress in the development of kynurenine and quinoline-3-carboxamide-derived drugs

Fanni Boros & László Vécsei

Pages: 1223-1247

Published online: 02 Sep 2020

AbstractforProgress in the development of kynurenine and quinoline-3-carboxamide-derived drugs | Full Text | References | PDF (863.3 KB) | EPUB

445 Views
15 CrossRef citations
0Altmetric

Therapeutic strategies for Parkinson’s disease: promising agents in early clinical development

Margherita Fabbri, Santiago Perez-Lloret & Olivier Rascol

Pages: 1249-1267

Published online: 02 Sep 2020

AbstractforTherapeutic strategies for Parkinson’s disease: promising agents in early clinical development | Full Text | References | PDF (900.4 KB) | EPUB

496 Views
6 CrossRef citations
0Altmetric

Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review

Cecilia Rustichelli, Flavia Lo Castro, Carlo Baraldi & Anna Ferrari

Pages: 1269-1275

Published online: 02 Sep 2020

AbstractforTargeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review | Full Text | References | PDF (254.3 KB) | EPUB

4289 Views
22 CrossRef citations
0Altmetric

Open Access

Novel therapeutic agents for the treatment of diabetic kidney disease

Rachel E. Hartman, P.S.S. Rao, Mariann D. Churchwell & Susan J. Lewis

Pages: 1277-1293

Published online: 14 Sep 2020

791 Views
9 CrossRef citations
0Altmetric

CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers

Ying Jiao, Ming Yi, Linping Xu, Qian Chu, Yongxiang Yan, Suxia Luo & Kongming Wu

Pages: 1295-1308

Published online: 08 Sep 2020

AbstractforCD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers | Full Text | References | PDF (1.9 MB) | EPUB

703 Views
16 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Early psoriatic arthritis: clinical and therapeutic challenges.

Francesco Caso et al.

Review Article | Published online: 23 Jul 2024

Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents

Elisabeth Amadeo et al.

Review Article | Published online: 22 Jul 2024

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Robert H. Gaffey et al.

Review Article | Published online: 17 Jul 2024

Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects

Jian Liu et al.

Article | Published online: 12 Jul 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.29, Iss.11, 2020)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?